Entheon Biomedical Corp. (ENTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
Jun 11, 2025, 4:00 PM EDT
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
1.12M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Entheon Biomedical News
- 2 months ago - Entheon Announces Change of Directors - Newsfile Corp
- 2 months ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 3 months ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 5 months ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp
- 3 years ago - Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets - Newsfile Corp
- 3 years ago - Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents - Newsfile Corp
- 3 years ago - Entheon Biomedical Announces Non-Brokered Private Placement Financing - Newsfile Corp
- 3 years ago - Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform - Newsfile Corp